Strongbridge Biopharma plc Uncategorized Contracts & Agreements
8 Contracts & Agreements
- Lock-Up Agreement, dated July 23, 2021, between Avenue Venture Opportunities Fund, L.P. and Strongbridge Biopharma plc (Filed With SEC on July 26, 2021)
- Amendment to Executive Chairman Agreement (Filed With SEC on April 10, 2020)
- Amendment to Option Award Agreements, dated as of November 26, 2019, by and between Strongbridge Biopharma plc and Matthew Pauls (Filed With SEC on February 28, 2020)
- Executive Chairman Agreement, dated as of November 1, 2019, by and between Strongbridge Biopharma plc and John Johnson (Filed With SEC on February 28, 2020)
- Description of Ordinary Shares (Filed With SEC on February 28, 2020)
- Strongbridge Biopharma plc 2017 Inducement Plan (Filed With SEC on February 27, 2019)
- Macrilen Acquisition Agreement, dated as of October 31, 2018, between Strongbridge Biopharma plc and Novo Nordisk Healthcare AG (Filed With SEC on October 31, 2018)
- Strongbridge Biopharma plc 2017 Inducement Plan (Filed With SEC on March 12, 2018)
